GAMCO Investors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
GAMCO Investors's AVEO Position: Q1 2023 in Review
GAMCO Investors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 121,277 shares — an estimated $1.81M sold.
GAMCO Investors first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $1.81M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- GAMCO Investors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- GAMCO Investors sold 121,277 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.81M.
- GAMCO Investors first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
- GAMCO Investors's AVEO Pharmaceuticals, Inc. position peaked at $1.81M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on GAMCO Investors's 13F filing for Q1 2023, filed 12 May 2023.